Researchers from the D'Or Institute for Research and Education (IDOR) have just published a study in the scientific journal Translational Psychiatry. The paper sought to elucidate the mechanisms involved in the cognitive deficits of human aging, considering the action of molecules that can fight inflammatory processes in neurodegenerative diseases such as Alzheimer's, and potentiate the endocannabinoid system. This substance, known as lipoxin A4, has been studied by researchers for years and this is its first application against neurodegenerative diseases linked to aging, with potential developments in the diagnostic field. This study was carried out in partnership with the Oswaldo Cruz Foundation (Fiocruz), Federal University of Rio de Janeiro (UFRJ), Federal University of Espírito Santo (UFES), Federal University of Latin American Integration (UNILA) and The Broad Institute of MIT and Harvard.